2024-03-28T11:33:30Zhttp://repisalud.isciii.es/oai/requestoai:repisalud.isciii.es:20.500.12105/93342022-10-06T12:55:25Zcom_20.500.12105_2174com_20.500.12105_2051com_20.500.12105_2173col_20.500.12105_2175
00925njm 22002777a 4500
dc
Barrio, Santiago
author
Munawar, Umair
author
Zhu, Yuan Xiao
author
Giesen, Nicola
author
Shi, Chang-Xin
author
Da Viá, Matteo
author
Sanchez, Richard
author
Bruins, Laura
author
Demler, Theresa
author
Müller, Nicole
author
Haertle, Larissa
author
Garitano, Andoni
author
Steinbrunn, Torsten
author
Danhof, Sophia
author
Cuenca, Isabel
author
Barrio-Garcia, Clara
author
Braggio, Esteban
author
Rosenwald, Andreas
author
Martinez-Lopez, Joaquin
author
Rasche, Leo
author
Raab, Marc S
author
Stewart, A Keith
author
Einsele, Hermann
author
Stühmer, Thorsten
author
Kortüm, K Martin
author
2019-09-26
Haematologica. 2019 pii: haematol.2019.217943.
0390-6078
http://hdl.handle.net/20.500.12105/9334
31558666
10.3324/haematol.2019.217943
1592-8721
Haematologica
CRL4/CRBN E3 ubiquitin ligase
Immunomodulatory drugs
Multiple Myeloma
Point mutations
Drug resistance
IKZF1/3 and CRL4-CRBN E3 ubiquitin ligase mutations and IMiD resistance in multiple myeloma